Work

Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease

Year: 2019

Type: letter

Abstract: We appreciate Mahler's correspondence related to our research statement (1), the goal of which was to identify knowledge gaps that future research studies can address to efficiently translate biomarkers into clinical practice.To reach this goal, we chose to focus on example biomarkers for select lung diseases rather than create a comprehensive list of all biomarkers for all pulmonary diseases.As stated in the article, "the biomarkers discussed in this research statement are not intended to be comprehensive."Thus, we did not state or intend to imply that fibrinogen is the "sole" biomarker in chronic obstructive pulmonary disease (COPD).We agree with Mahler that the peak inspiratory flow rate is a promising COPD biomarker, and encourage studies of this and other promising biomarkers for COPD and other lung diseases.

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.201902-0432le

Authors: Ann Chen Wu, Blanca E. Himes

Institutions: Harvard University, Harvard Pilgrim Health Care, University of Pennsylvania

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2952350190

Cites: 1

Cited by:

Related to: 10